Heterozygous missense variant in GLI2 impairs human endocrine pancreas development

Laura M. Mueller,Abigail Isaacson,Heather Wilson,Anna Salowka,Isabel Tay,Maolian Gong,Nancy Samir Elbarbary,Klemens Raile,Francesca M. Spagnoli

DOI: https://doi.org/10.1038/s41467-024-46740-8

IF: 16.6

2024-03-20

Nature Communications

Abstract:Abstract Missense variants are the most common type of coding genetic variants. Their functional assessment is fundamental for defining any implication in human diseases and may also uncover genes that are essential for human organ development. Here, we apply CRISPR-Cas9 gene editing on human iPSCs to study a heterozygous missense variant in GLI2 identified in two siblings with early-onset and insulin-dependent diabetes of unknown cause. GLI2 is a primary mediator of the Hedgehog pathway, which regulates pancreatic β-cell development in mice. However, neither mutations in GLI2 nor Hedgehog dysregulation have been reported as cause or predisposition to diabetes. We establish and study a set of isogenic iPSC lines harbouring the missense variant for their ability to differentiate into pancreatic β-like cells. Interestingly, iPSCs carrying the missense variant show altered GLI2 transcriptional activity and impaired differentiation of pancreatic progenitors into endocrine cells. RNASeq and network analyses unveil a crosstalk between Hedgehog and WNT pathways, with the dysregulation of non-canonical WNT signaling in pancreatic progenitors carrying the GLI2 missense variant. Collectively, our findings underscore an essential role for GLI2 in human endocrine development and identify a gene variant that may lead to diabetes.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to determine whether a specific genetic variation is related to the occurrence of diabetes and explore its underlying mechanisms. Specifically, the researchers found a heterozygous missense variation (p.P1554L) in the GLI2 gene in two siblings with early - onset and unexplained insulin - dependent diabetes. GLI2 is a major mediator of the Hedgehog signaling pathway and is known to play an important role in the development of pancreatic β - cells in mice. However, there have been no previous reports indicating that GLI2 mutations or Hedgehog signaling dysregulation can lead to diabetes.

To verify whether this variation can affect the development of human pancreatic endocrine cells and thus lead to diabetes, the researchers introduced this heterozygous missense variation into human induced pluripotent stem cells (iPSCs) using CRISPR - Cas9 gene - editing technology and studied the ability of these cells to differentiate into pancreatic β - like cells. The research results show that iPSCs carrying this variation exhibit impaired GLI2 transcriptional activity and a weakened ability of pancreatic progenitor cells to differentiate into endocrine cells. RNA sequencing and network analysis further revealed the interaction between the Hedgehog and WNT signaling pathways, especially the abnormal regulation of non - canonical WNT signaling in pancreatic progenitor cells carrying the GLI2 missense variation.

Overall, this study aims to determine the significance of this specific genetic variation in human diseases through functional assessment, especially its impact on pancreatic development and its relationship with the onset of diabetes. This not only helps to understand the genetic basis of diabetes but may also provide clues for new treatment strategies.